Previous studies have confirmed that inhibiting PRKCSH can induce autophagy and/or apoptosis in cancer cells through several pathways, such as the p53-dependent manner in lung carcinoma cells, mTOR-dependent pathway in Hela cells, and excessive ER stress in hepatocellular carcinoma16–18. Here, TP53 is linked to lung carcinoma.